Dr Michael Morton will be speaking at EUROTOX this September in Belgium.  On Tuesday September 4^th at 16:30 in Hall 100 Mike will address ‘Cardiac safety: current state of the art’ chaired by Dr Mark Holbrook of VAST Pharma solutions and Ester Lovsin-Barle from Lonza.  Mike will present ‘Ion channel profiling of stem cell-derived cardiomyocytes: Useful reagents for automated patch-clamp?’

Drawing on research carried out last year and presented as a poster at Safety Pharmacology Society Annual Meeting 2017 in Berlin, Mike will discuss his experience with stem cell-derived cardiomyocytes. These cells were sourced from different manufacturers and tested by automated patch-clamp. Sodium and calcium channel currents were recorded, as were cardiac action potentials. The presentation will address whether these cells are a viable and useful reagent for ion channel screening.

EUROTOX is being held in Brussels this year and runs the 2^nd to 5^th of September 2018.  For more information see the EUROTOX website.  See the full programme here.